Back to Newsroom
Back to Newsroom

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

Friday, 09 August 2024 10:00 AM

Biofrontera Inc.

WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2024 on Wednesday, August 14, 2024. The results will be released after the market close on Wednesday, Aug 14 and the company will host a conference call on Thursday, August 15 at 10:00am Eastern Time.

Conference Call and Webcast Information

Event

Biofrontera Inc. Second Quarter 2024 Financial Results and Business Update Conference Call

Date

Thursday, August 15, 2024

Time

10:00am ET

Conference Call

1-877-877-1275 (U.S.)

1-412-858-5202 (international)

Webcast

https://event.choruscall.com/mediaframe/webcast.html?webcastid=bU2HFqrt

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Investor Relations
Andrew Barwicki
1-516-662-9461
[email protected]

SOURCE: Biofrontera Inc.

Topic:
Conference Call
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: